Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Burt Nabors

Showing results (1-10 of 85) with videos related to

Pageof 9
Sort By:
Journal of the National Comprehensive Cancer Network : JNCCN|September 6, 2014
The role of bevacizumab in glioblastomaL Burt Nabors
Current Treatment Options in Oncology|October 29, 2004
Targeted molecular therapy for malignant gliomasL Burt Nabors
Neuro-Oncology|May 27, 2017
When less is better: care of the elderly with glioblastomaL Burt Nabors
Expert Review of Neurotherapeutics|July 20, 2005
Treatment of adults with recurrent malignant gliomaL Burt Nabors, John Fiveash
Neuro-Oncology|March 8, 2020
A troublesome burden, the amplification of EGFR in glioblastoma!Mina Lobbous, L Burt Nabors
Handbook of Clinical Neurology|March 8, 2016
Complications from pharmacotherapyL Burt Nabors, Birgit Surboeck, Wolfgang Grisold
Neuro-Oncology|December 1, 2020
Mapping uncharted territory: a gene expression signature for precision glioblastoma therapeuticsKasey R Skinner, L Burt Nabors, C Ryan Miller
The Journal of Biological Chemistry|July 26, 2012
Phosphoregulation of the RNA-binding protein Hu antigen R (HuR) by Cdk5 affects centrosome functionNatalia Filippova, Xiuhua Yang, Peter King, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|November 2, 2014
Role of MRI in primary brain tumor evaluationDenise Leung, Xiaosi Han, Tom Mikkelsen, et al.
Expert Opinion on Investigational Drugs|July 12, 2008
Cilengitide: an integrin-targeting arginine-glycine-aspartic acid peptide with promising activity for glioblastoma multiformeDavid A Reardon, L Burt Nabors, Roger Stupp, et al.
Pageof 9

Showing results (1-10 of 85) with videos related to

Sort By:
Pageof 9
Journal of the National Comprehensive Cancer Network : JNCCN|September 6, 2014
The role of bevacizumab in glioblastomaL Burt Nabors
Current Treatment Options in Oncology|October 29, 2004
Targeted molecular therapy for malignant gliomasL Burt Nabors
Neuro-Oncology|May 27, 2017
When less is better: care of the elderly with glioblastomaL Burt Nabors
Expert Review of Neurotherapeutics|July 20, 2005
Treatment of adults with recurrent malignant gliomaL Burt Nabors, John Fiveash
Neuro-Oncology|March 8, 2020
A troublesome burden, the amplification of EGFR in glioblastoma!Mina Lobbous, L Burt Nabors
Handbook of Clinical Neurology|March 8, 2016
Complications from pharmacotherapyL Burt Nabors, Birgit Surboeck, Wolfgang Grisold
Neuro-Oncology|December 1, 2020
Mapping uncharted territory: a gene expression signature for precision glioblastoma therapeuticsKasey R Skinner, L Burt Nabors, C Ryan Miller
The Journal of Biological Chemistry|July 26, 2012
Phosphoregulation of the RNA-binding protein Hu antigen R (HuR) by Cdk5 affects centrosome functionNatalia Filippova, Xiuhua Yang, Peter King, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|November 2, 2014
Role of MRI in primary brain tumor evaluationDenise Leung, Xiaosi Han, Tom Mikkelsen, et al.
Expert Opinion on Investigational Drugs|July 12, 2008
Cilengitide: an integrin-targeting arginine-glycine-aspartic acid peptide with promising activity for glioblastoma multiformeDavid A Reardon, L Burt Nabors, Roger Stupp, et al.
Pageof 9